Mesenchymal stem cells induce endothelial cell quiescence and promote capillary formation

Stem Cell Research and Therapy

Volumn 5, Issue 1, 2014, Pages

  Pedersen, Torbjorn O ^a,b   Blois, Anna L ^b,c   Xue, Ying ^a   Xing, Zhe ^a   Sun, Yang ^d   Finne Wistrand, Anna ^d   Lorens, James B ^b   Fristad, Inge ^a   Leknes, Knut N ^a   Mustafa, Kamal ^a  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD11B ANTIGEN; CD31 ANTIGEN; COLONY STIMULATING FACTOR 1; FIBROBLAST GROWTH FACTOR 1; PLATELET DERIVED GROWTH FACTOR B; TRANSGELIN; VASCULOTROPIN A; VON WILLEBRAND FACTOR; PLATELET DERIVED GROWTH FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CAPILLARY DENSITY; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE ENGINEERING; UPREGULATION; VASCULAR ENDOTHELIUM; ANIMAL; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; GENETICS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METABOLISM; NONOBESE DIABETIC MOUSE; PHYSIOLOGY; SCID MOUSE; TISSUE SCAFFOLD; UMBILICAL VEIN ENDOTHELIAL CELL;

MUS;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 1; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED NOD; MICE, SCID; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET-DERIVED GROWTH FACTOR; TISSUE ENGINEERING; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84895495214     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt412     Document Type: Article

References (35)

1. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Benjamin LE, Hemo I, Keshet E, Development 1998 125 1591 1598 9521897
2. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Friedenstein AJ, Chailakhjan RK, Lalykina KS, Cell Tissue Kinet 1970 3 393 403 5523063
3. Mesenchymal stem cells. Caplan AI, J Orthop Res 1991 9 641 650 10.1002/jor.1100090504 1870029
4. Mesenchymal stem cells: revisiting history, concepts, and assays. Bianco P, Robey PG, Simmons PJ, Cell Stem Cell 2008 2 313 319 10.1016/j.stem.2008.03. 002 18397751
5. Endothelial/pericyte interactions. Armulik A, Abramsson A, Betsholtz C, Circ Res 2005 97 512 523 10.1161/01.RES.0000182903.16652.d7 16166562
6. Role of pericytes in vascular morphogenesis. Betsholtz C, Lindblom P, Gerhardt H, EXS 2005 94 115 125 15617474
7. Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Stratman AN, Malotte KM, Mahan RD, Davis MJ, Davis GE, Blood 2009 114 5091 5101 10.1182/blood-2009-05-222364 19822899
8. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-beta in vascular morphogenesis. Holderfield MT, Hughes CC, Circ Res 2008 102 637 652 10.1161/CIRCRESAHA.107.167171 18369162
9. Pericytes promote endothelial cell survival through induction of autocrine VEGF-A signaling and Bcl-w expression. Franco M, Roswall P, Cortez E, Hanahan D, Pietras K, Blood 2011 118 2906 2917 10.1182/blood-2011-01-331694 21778339
10. Endothelial-mesenchymal interactions in vitro reveal molecular mechanisms of smooth muscle/pericyte differentiation. Ding R, Darland DC, Parmacek MS, D'Amore PA, Stem Cells Dev 2004 13 509 520 10.1089/scd.2004.13.509 15588508
11. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. Hirschi KK, Rohovsky SA, D'Amore PA, J Cell Biol 1998 141 805 814 10.1083/jcb.141.3.805 9566978
12. Efficient in vivo vascularization of tissue-engineering scaffolds. Hegen A, Blois A, Tiron CE, Hellesoy M, Micklem DR, Nor JE, Akslen LA, Lorens JB, J Tissue Eng Regen Med 2011 5 52 e62 10.1002/term.336 20865694
13. Pre-vascularization of in vitro three-dimensional tissues created by cell sheet engineering. Asakawa N, Shimizu T, Tsuda Y, Sekiya S, Sasagawa T, Yamato M, Fukai F, Okano T, Biomaterials 2010 31 3903 3909 10.1016/j.biomaterials.2010. 01.105 20170957
14. Mural cell associated VEGF is required for organotypic vessel formation. Evensen L, Micklem DR, Blois A, Berge SV, Aarsaether N, Littlewood-Evans A, Wood J, Lorens JB, PLoS One 2009 4 5798 10.1371/journal.pone.0005798 19495422
15. Osteogenic stimulatory conditions enhance growth and maturation of endothelial cell microvascular networks in culture with mesenchymal stem cells. Pedersen TO, Blois AL, Xue Y, Xing Z, Cottler-Fox M, Fristad I, Leknes KN, Lorens JB, Mustafa K, J Tissue Eng 2012 3 2041731412443236 22511994
16. Elastomeric hydrolyzable porous scaffolds: copolymers of aliphatic polyesters and a polyether-ester. Odelius K, Plikk P, Albertsson AC, Biomacromolecules 2005 6 2718 2725 10.1021/bm050190b 16153111
17. Effect of endothelial cells on bone regeneration using poly(L-lactide-co-1,5-dioxepan-2-one) scaffolds. Xing Z, Xue Y, Danmark S, Schander K, Ostvold S, Arvidson K, Hellem S, Finne-Wistrand A, Albertsson AC, Mustafa K, J Biomed Mater Res A 2011 96 349 357 21171154
18. Comparison of short-run cell seeding methods for poly(L-lactide-co-1,5- dioxepan-2-one) scaffold intended for bone tissue engineering. Xing Z, Xue Y, Danmark S, Finne-Wistrand A, Arvidson K, Hellem S, Yang ZQ, Mustafa K, Int J Artif Organs 2011 34 432 441 10.5301/IJAO.2011.8319 21574158
19. Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Augustin HG, Koh GY, Thurston G, Alitalo K, Nat Rev Mol Cell Biol 2009 10 165 177 10.1038/nrm2639 19234476
20. Angiopoietins assemble distinct Tie2 signalling complexes in endothelial cell-cell and cell-matrix contacts. Saharinen P, Eklund L, Miettinen J, Wirkkala R, Anisimov A, Winderlich M, Nottebaum A, Vestweber D, Deutsch U, Koh GY, Olsen BR, Alitalo K, Nat Cell Biol 2008 10 527 537 10.1038/ncb1715 18425119
21. The pericyte: cellular regulator of microvascular blood flow. Kutcher ME, Herman IM, Microvasc Res 2009 77 235 246 10.1016/j.mvr.2009.01.007 19323975
22. Osteogenic and angiogenic potentials of monocultured and co-cultured human-bone-marrow-derived mesenchymal stem cells and human-umbilical-vein endothelial cells on three-dimensional porous beta-tricalcium phosphate scaffold. Kang Y, Kim S, Fahrenholtz M, Khademhosseini A, Yang Y, Acta Biomater 2013 9 4906 4915 10.1016/j.actbio.2012.08.008 22902820
23. Regulation of smooth muscle actin expression and contraction in adult human mesenchymal stem cells. Kinner B, Zaleskas JM, Spector M, Exp Cell Res 2002 278 72 83 10.1006/excr.2002.5561 12126959
24. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Au P, Tam J, Fukumura D, Jain RK, Blood 2008 111 4551 4558 10.1182/blood-2007-10-118273 18256324
25. Connexin45 regulates endothelial-induced mesenchymal cell differentiation toward a mural cell phenotype. Fang JS, Dai C, Kurjiaka DT, Burt JM, Hirschi KK, Arterioscler Thromb Vasc Biol 2013 33 362 368 10.1161/ATVBAHA.112.255950 23220276
26. Equal modulation of endothelial cell function by four distinct tissue-specific mesenchymal stem cells. Lin RZ, Moreno-Luna R, Zhou B, Pu WT, Melero-Martin JM, Angiogenesis 2012 15 443 455 10.1007/s10456-012-9272-2 22527199
27. Endothelial microvascular networks affect gene expression profiles and osteogenic potential of tissue-engineered constructs. Pedersen TO, Blois AL, Xing Z, Xue Y, Sun Y, Finne-Wistrand A, Akslen LA, Lorens JB, Leknes KN, Fristad I, Mustafa K, Stem Cell Res Ther 2013 4 52 10.1186/scrt202 23683577
28. Co-culture of mesenchymal stem cells with umbilical vein endothelial cells under hypoxic condition. Zhang B, Yang S, Zhang Y, Sun Z, Xu W, Ye S, J Huazhong Univ Sci Technolog Med Sci 2012 32 173 180 10.1007/s11596-012-0031-9 22528216
29. Luciferase labeling for multipotent stromal cell tracking in spinal fusion versus ectopic bone tissue engineering in mice and rats. Geuze RE, Prins HJ, Oner FC, van der Helm YJ, Schuijff LS, Martens AC, Kruyt MC, Alblas J, Dhert WJ, Tissue Eng Part A 2010 16 3343 3351 10.1089/ten.tea.2009.0774 20575656
30. Fate of bone marrow stromal cells in a syngenic model of bone formation. Boukhechba F, Balaguer T, Bouvet-Gerbettaz S, Michiels JF, Bouler JM, Carle GF, Scimeca JC, Rochet N, Tissue Eng Part A 2011 17 2267 2278 10.1089/ten.tea.2010. 0461 21539494
31. 26S proteasome regulation of Ankrd1/CARP in adult rat ventricular myocytes and human microvascular endothelial cells. Samaras SE, Chen B, Koch SR, Sawyer DB, Lim CC, Davidson JM, Biochem Biophys Res Commun 2012 425 830 835 10.1016/j.bbrc.2012.07.162 22892129
32. CXCL17 expression by tumor cells recruits CD11b + Gr1 high F4/80- cells and promotes tumor progression. Matsui A, Yokoo H, Negishi Y, Endo-Takahashi Y, Chun NA, Kadouchi I, Suzuki R, Maruyama K, Aramaki Y, Semba K, Kobayashi E, Takahashi M, Murakami T, PLoS One 2012 7 44080 10.1371/journal.pone.0044080 22952881
33. Mesenchymal stem cells: immunobiology and role in immunomodulation and tissue regeneration. Kode JA, Mukherjee S, Joglekar MV, Hardikar AA, Cytotherapy 2009 11 377 391 10.1080/14653240903080367 19568970
34. Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Abdi R, Fiorina P, Adra CN, Atkinson M, Sayegh MH, Diabetes 2008 57 1759 1767 10.2337/db08-0180 18586907
35. VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma. Beckermann BM, Kallifatidis G, Groth A, Frommhold D, Apel A, Mattern J, Salnikov AV, Moldenhauer G, Wagner W, Diehlmann A, Saffrich R, Schubert M, Ho AD, Giese N, Büchler MW, Friess H, Büchler P, Herr I, Br J Cancer 2008 99 622 631 10.1038/sj.bjc.6604508 18665180